AU4033593A - Modulation of thrombospondin-CD36 interactions - Google Patents

Modulation of thrombospondin-CD36 interactions

Info

Publication number
AU4033593A
AU4033593A AU40335/93A AU4033593A AU4033593A AU 4033593 A AU4033593 A AU 4033593A AU 40335/93 A AU40335/93 A AU 40335/93A AU 4033593 A AU4033593 A AU 4033593A AU 4033593 A AU4033593 A AU 4033593A
Authority
AU
Australia
Prior art keywords
thrombospondin
interactions
modulation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU40335/93A
Other languages
English (en)
Inventor
Russell John Howard
Lawrence Lit-King Leung
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Leland Stanford Junior University
Merck Sharp and Dohme LLC
Original Assignee
Leland Stanford Junior University
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leland Stanford Junior University, Schering Corp filed Critical Leland Stanford Junior University
Publication of AU4033593A publication Critical patent/AU4033593A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU40335/93A 1992-04-30 1993-04-28 Modulation of thrombospondin-CD36 interactions Abandoned AU4033593A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US87628792A 1992-04-30 1992-04-30
US876287 1992-04-30
US926093A 1993-01-25 1993-01-25
US009260 1993-01-25

Publications (1)

Publication Number Publication Date
AU4033593A true AU4033593A (en) 1993-11-29

Family

ID=26679269

Family Applications (1)

Application Number Title Priority Date Filing Date
AU40335/93A Abandoned AU4033593A (en) 1992-04-30 1993-04-28 Modulation of thrombospondin-CD36 interactions

Country Status (5)

Country Link
EP (1) EP0640100A1 (fr)
JP (1) JPH07503024A (fr)
AU (1) AU4033593A (fr)
CA (1) CA2134655A1 (fr)
WO (1) WO1993022340A1 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5367059A (en) * 1992-05-14 1994-11-22 W. R. Grace & Co.-Conn. Cys-Ser-Val-Thr-Cys-Gly specific tumor cell adhesion receptor
WO1996033218A1 (fr) * 1995-04-21 1996-10-24 Allelix Biopharmaceuticals Inc. Peptides anti-hemorragiques
GB9509957D0 (en) * 1995-05-17 1995-07-12 Khalil Nasreen Post-translational activation of tgf-›1 involving the tsp-1 receptor cd36
US5611334A (en) 1995-07-07 1997-03-18 Muchin Jerome D Nose dilator device
US6098616A (en) 1998-03-13 2000-08-08 Acutek International Non-linear nasal dilator
CN106317191B (zh) * 2015-06-23 2019-09-17 首都医科大学 Thr-Val-Gly-Cys-Ser,其合成,活性和应用
CN106279362B (zh) * 2015-06-23 2019-07-12 首都医科大学 Arg-Leu-Val-Cys-Val，其合成，药理活性和应用
ITUB20152122A1 (it) 2015-07-13 2017-01-13 Roberto Avataneo Dispositivo dilatatore nasale.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5200397A (en) * 1990-02-22 1993-04-06 W. R. Grace & Co.-Conn. Use of peptide analogs of thrombospondin for the inhibition of angiogenic activity
KR100206524B1 (ko) * 1990-07-13 1999-07-01 어니스트 엠. 해데드 씨디 53 세포 표면 항원 및 그를 암호화하는 재조합 디엔에이
EP1069137A1 (fr) * 1990-09-24 2001-01-17 W.R. Grace & Co.-Conn. Peptides ayant une activité de type thrombospondine et leur utilisation thérapeutique

Also Published As

Publication number Publication date
WO1993022340A1 (fr) 1993-11-11
JPH07503024A (ja) 1995-03-30
CA2134655A1 (fr) 1993-11-11
EP0640100A1 (fr) 1995-03-01

Similar Documents

Publication Publication Date Title
AU4166393A (en) Auto-reclosers
AU2771792A (en) Novel cosmetic
AU4152293A (en) Closure
AU3561193A (en) TNF-muteins
AU3991693A (en) Pyrazinoindoles
AU3441393A (en) Urea-hydrogen peroxide-polyvinylpyrrolidone
AU3803593A (en) Compounds
AU4177593A (en) Benzophenonehydrazones
AU3042892A (en) Rockbolt
AU685767B2 (en) Substituted benzazepinones
AU4156393A (en) Heterocyclyltriazolinones
AU5184393A (en) Substituted derivatives of diaminophthalimide
AU4033593A (en) Modulation of thrombospondin-CD36 interactions
AU6723294A (en) Use of simmondsine
AU664253B2 (en) Photo-deviometer
AU3461693A (en) Saddle-cloth
AU3562193A (en) Morpholin- and thiomorpholin-4-ylamides
AU4164793A (en) Heterocyclyltriazolinones
AU5371694A (en) Use of the tarchonanthus camphoratus
AU4632493A (en) Weathershed
AU1343092A (en) Reproduction of holograms
AU3048492A (en) New compounds
AU4419693A (en) Micro-emulsion of dexniguldipin
AU3185693A (en) Pyrrolylbenzodiazepinones
AU4864693A (en) Alkoxymethyl-substituted pyridonebiphenyls